Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors (Q36879421)
Jump to navigation
Jump to search
scientific article published on 9 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors |
scientific article published on 9 March 2016 |
Statements
1 reference
Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors (English)
1 reference
1 reference
Frank V Fossella
1 reference
Manisha H Shah
1 reference
Mary E R O'Brien
1 reference
Kathleen N Moore
1 reference
Shailender Bhatia
1 reference
Maurice Kirby
1 reference
Penella J Woll
1 reference
1 reference
9 March 2016
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference